Lomas de Zamora, Argentina

Centro de Ojos Loria

Macular Edema

Edema

RO7200220

Vamikibart

Roche

condition

allSponsorName

gender

Male

Female

overallStatus

Recruiting

Not yet recruiting

Active, not recruiting

Enrolling by invitation

Completed

Terminated

Withdrawn

Suspended

Unknown

type

Interventional

Observational

Expanded Access

phase

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Not Applicable

funderTypes

Industry

Other U.S. Federal agency

All others

ageGroup

Child (birth-17)

Adult (18-64)

Older Adult (65+)

Study BP43445 is a phase II, multicenter, randomized, double-masked, active comparator-controlled study to investigate the efficacy, safety, tolerability, pharmacokinetics, and pharmacodynamics of vamikibart administered intravitreally in participants with diabetic macular edema. Only one eye will be chosen as the study eye. The duration of the study will be up to 76 weeks.

A Study to Investigate Vamikibart (RO7200220) in Diabetic Macular Edema

Centro de Ojos Loria | Lomas de Zamora, Argentina

Site insights

Work at this site?

Active trials

A Study to Investigate Vamikibart (RO7200220) in Diabetic Macular Edema

Trial sponsors